NCT07389876
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
- Locations
-
- Wanjing Feng Shanghai, Shanghai Municipality, China
Clinical trial condition
Second-line Treatment
Explore clinical trials studying Second-line Treatment. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Second-line Treatment trial results
NCT06446154
- Conditions
- Adenocarcinoma, Anti-angiogenic Therapy, Carcinoma, +12 more
- Locations
-
- Sun Yat-sen university cancer center Guangzhou, Guangdong, China
NCT06666582
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer Stage IV, +8 more
- Locations
-
- Hellenic Oncology Cooperative Group Athens, Greece
NCT03251443
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +5 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT01379534
- Conditions
- Carcinoma, Endometrial Cancer, Endometrial Neoplasms, +16 more
- Locations
-
- University of South Alabama / Mitchell Cancer Institute Univ South Alabama Mobile, Alabama, United States
- St. Jude Heritage Medical Group St Jude Fullerton, California, United States
- USC/Kenneth Norris Comprehensive Cancer Center USC 2 Los Angeles, California, United States
- Cedars Sinai Medical Center TKI258A2211 (SC) Los Angeles, California, United States
Active, Not Recruiting
Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
NCT06518018
- Conditions
- Advanced Stage NSCLC, Barakat syndrome, Bronchial Neoplasms, +11 more
- Locations
-
- The Second People's Hospital of Neijiang Neijiang, Sichuan, China